In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani

Phytomedicine

Volumn 14, Issue 1, 2007, Pages 36-42

  Lakshmi, V ^a   Pandey, K ^a   Kapil, A ^a   Singh, N ^a   Samant, M ^a   Dube, A ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Amastigote; Antileishmanial; Dysoxylum binectariferum; Hamster; Leishmania donovani; Promastigotes

Indexed keywords

ANTILEISHMANIAL AGENT; DYSOXYLUM BINECTARIFERUM EXTRACT; MILTEFOSINE; ROHITUKINE; STIBOGLUCONATE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BARK; CONTROLLED STUDY; DRUG DOSE COMPARISON; DYSOXYLUM BINECTARIFERUM; EXPERIMENTAL INFECTION; INDIA; LEISHMANIA DONOVANI; MACROPHAGE; MALE; MEDICINAL PLANT; MELIACEAE; NONHUMAN; PLANT STEM; PRIORITY JOURNAL; PROMASTIGOTE; SYRIAN HAMSTER; TRADITIONAL MEDICINE; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; CRICETINAE; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MELIACEAE; MESOCRICETUS; PARASITIC SENSITIVITY TESTS; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS;

CRICETINAE; DYSOXYLUM; LEISHMANIA DONOVANI;

EID: 33845671368     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2005.10.002     Document Type: Article

References (19)

1. Akedengue B., Ngou-Milama E., Laurens A., and Hocquemiller R. Recent advances in the fight against leishmaniasis with natural products. Parasite 6 (1999) 3-8
2. Albersberg W., and Singh Y. Dammarane triterpenoids from the fruits of Dysoxylum richii. Phytochemistry 30 (1991) 921-926
3. Anonymous. Wealth of India - Raw Materials vol. III (D-E) (1952), Council of Scientific and Industrial Research, New Delhi pp. 119-121
4. Carlson B.A., Dubay M.M., Sausville E.A., Brizuela L., and Worland P.J. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK (4) in human breast carcinoma cells. Cancer Res. 56 (1996) 2973-2978
5. Fournet A., and Munoz V. Natural products as trypanocidal, antileishmanial and antimalarial drugs. Curr. Top. Med. Chem. 2 (2002) 1215-1237
6. Guru P.Y., Agarwal A.K., Singha U.K., Singhal A., and Gupta C.M. Drug targeting in Leishmania donovani infections using tuftsin bearing liposomes as drug vehicles. FEBS Lett. 245 (1989) 204-208
7. Jain S.K., and DeFilipps R.A. Medicinal Plants of India vol. I (1991), Reference Publications Inc., Michigan, USA
8. Luo X.D., Wu S.H., Wu D.G., Ma Y.B., and Qi S.H. Novel antifeeding limonoids from Dysoxylum hainanense. Tetrahedron 58 (2002) 7797-7804
9. Melby P.C., Chandrasekar B., Zhao W., and Coe J.E. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J. Immunol. 166 (2001) 1912-1920
10. Mendonça-Filho R.R., Rodrigues I.A., Alviano D.S., Santos A.L.S., Soares R.M.A., Alviano C.S., Lopes A., and Rosa M.S. Leishmanicidal activity of polyphenolic-rich extract from husk fiber of Cocos nucifera Linn. (Palmae). Res. Microbiol. 155 (2004) 136-143
11. Murray H.W. Treatment of visceral leishmanisis in 2004. Am. J. Trop. Med. Hyg. 71 (2004) 787-794
12. Naik R.J., Kattige S.L., Vasudev B.S., Alreja B., DeSouza N.J., and Rupp R.H. An anti-inflammatory and immunomodulatory piperidinyl benzopyranone from Dysoxylum binectariferum: isolation, structure and total synthesis. Tetrahedron 44 (1988) 2081-2086
13. Rocha L.G., Almeida J.R.G.S., Macedo R.O., and Barbosa-Filho J.M. A review of natural products with antileishmanial activity. Phytomedicine 12 (2005) 514-535
14. Sedlacek H.H., Czeck J., Naik R., Kaur G., Worland P., Losiewicz M., Parker B., Carlson B., Smith A., Senderowicz A., and Sausville E. Flavopiridol (L 8608275, NSC 649890), a new kinase inhibitor for tumor therapy. Int. J. Oncol. 9 (1996) 1143-1168
15. Sharma P., Rastogi S., Bhatnagar S., Srivastava J.K., Dube A., Guru P.Y., Kulshreshtha D.K., and Dhawan B.N. Antileishmanial action of a plant Tephrosia pupurea and its fractions against experimental visceral leishmaniasis. Drug Dev. Res. 60 (2003) 285-293
16. Sharma P., Singh N., Garg R., Haq W., and Dube A. Efficacy of human β-casein fragment (54-59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters. Peptides 25 (2004) 1873-1881
17. Singh S., Garg H.S., and Khanna N.M. Dysobinin, a new tetranortriterpene from Dysoxylum binectariferum. Phytochemistry 15 (1976) 2001-2002
18. Singh N., Mishra P.K., Kapil A., Arya K.R., Maurya R., and Dube A. Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis. J. Ethnopharmacol. 98 (2005) 83-88
19. Sundar S., More D.K., Singh M.K., Singh V.P., Sharma S., Makharia A., Kumar P.C., and Murray H.W. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin. Infect. Dis. 31 (2000) 1104-1106